Literature DB >> 27158672

Functional significance of the discordance between transcriptional profile and left ventricular structure/function during reverse remodeling.

Veli K Topkara1, Kari T Chambers1, Kai-Chien Yang2, Huei-Ping Tzeng1, Sarah Evans1, Carla Weinheimer1, Attila Kovacs1, Jeffrey Robbins3, Philip Barger1, Douglas L Mann1.   

Abstract

To elucidate the mechanisms for reverse LV remodeling, we generated a conditional (doxycycline [dox] off) transgenic mouse tetracycline transactivating factor-TRAF2 (tTA-TRAF2) that develops a dilated heart failure (HF) phenotype upon expression of a proinflammatory transgene, TNF receptor-associated factor 2 (TRAF2), and complete normalization of LV structure and function when the transgene is suppressed. tTA-TRAF2 mice developed a significant increase in LV dimension with decreased contractile function, which was completely normalized in the tTA-TRAF2 mice fed dox for 4 weeks (tTA-TRAF2dox4W). Normalization of LV structure and function was accompanied by partial normalization (~60%) of gene expression associated with incident HF. Similar findings were observed in patients with dilated cardiomyopathy who underwent reverse LV remodeling following mechanical circulatory support. Persistence of the HF gene program was associated with an exaggerated hypertrophic response and increased mortality in tTA-TRAF2dox4W mice following transaortic constriction (TAC). These effects were no longer observed following TAC in tTA-TRAF2dox8W, wherein there was a more complete (88%) reversal of the incident HF genes. These results demonstrate that reverse LV remodeling is associated with improvements in cardiac myocyte biology; however, the persistence of the abnormal HF gene program may be maladaptive following perturbations in hemodynamic loading conditions.

Entities:  

Year:  2016        PMID: 27158672      PMCID: PMC4855517          DOI: 10.1172/jci.insight.86038

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  31 in total

1.  Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.

Authors:  Pratima Malekar; Marco Hagenmueller; Adamma Anyanwu; Sebastian Buss; Marcus R Streit; Celine S Weiss; David Wolf; Johannes Riffel; Alexander Bauer; Hugo A Katus; Stefan E Hardt
Journal:  Hypertension       Date:  2010-02-22       Impact factor: 10.190

2.  Rehospitalization for heart failure: predict or prevent?

Authors:  Akshay S Desai; Lynne W Stevenson
Journal:  Circulation       Date:  2012-07-24       Impact factor: 29.690

3.  Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading.

Authors:  M Flesch; K B Margulies; H C Mochmann; D Engel; N Sivasubramanian; D L Mann
Journal:  Circulation       Date:  2001-11-06       Impact factor: 29.690

4.  Regression of pressure overload-induced left ventricular hypertrophy in mice.

Authors:  Xiao-Ming Gao; Helen Kiriazis; Xiao-Lei Moore; Xin-Heng Feng; Karen Sheppard; Anthony Dart; Xiao-Jun Du
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-21       Impact factor: 4.733

5.  Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury.

Authors:  Yasushi Sakata; Jian-Wen Dong; Jesus G Vallejo; Chien-Hua Huang; J Scott Baker; Kevin J Tracey; Osamu Tacheuchi; Shizuo Akira; Douglas L Mann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-09-15       Impact factor: 4.733

6.  Load-dependent and -independent regulation of proinflammatory cytokine and cytokine receptor gene expression in the adult mammalian heart.

Authors:  Georg Baumgarten; Pascal Knuefermann; Dinesh Kalra; Feng Gao; George E Taffet; Lloyd Michael; Perry J Blackshear; Ester Carballo; Natarajan Sivasubramanian; Douglas L Mann
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

7.  Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart.

Authors:  Pascal Knuefermann; Yasushi Sakata; J Scott Baker; Chien-Hua Huang; Kenichi Sekiguchi; Hordur S Hardarson; Osamu Takeuchi; Shizuo Akira; Jesus G Vallejo
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

8.  Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support.

Authors:  Kai-Chien Yang; Kathryn A Yamada; Akshar Y Patel; Veli K Topkara; Isaac George; Faisal H Cheema; Gregory A Ewald; Douglas L Mann; Jeanne M Nerbonne
Journal:  Circulation       Date:  2014-01-15       Impact factor: 29.690

9.  Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profile.

Authors:  William E Stansfield; Peter C Charles; Ru-hang Tang; Mauricio Rojas; Rajendra Bhati; Nancy C Moss; Cam Patterson; Craig H Selzman
Journal:  J Thorac Cardiovasc Surg       Date:  2009-01       Impact factor: 5.209

10.  Desmin mediates TNF-alpha-induced aggregate formation and intercalated disk reorganization in heart failure.

Authors:  Panagiota Panagopoulou; Constantinos H Davos; Derek J Milner; Emily Varela; Joann Cameron; Douglas L Mann; Yassemi Capetanaki
Journal:  J Cell Biol       Date:  2008-06-02       Impact factor: 10.539

View more
  11 in total

1.  Widespread Down-Regulation of Cardiac Mitochondrial and Sarcomeric Genes in Patients With Sepsis.

Authors:  Scot J Matkovich; Belal Al Khiami; Igor R Efimov; Sarah Evans; Justin Vader; Ashwin Jain; Bernard H Brownstein; Richard S Hotchkiss; Douglas L Mann
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

2.  Impaired Protein Quality Control During Left Ventricular Remodeling in Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor.

Authors:  Justin Hartupee; Gabor D Szalai; Wei Wang; Xiucui Ma; Abhinav Diwan; Douglas L Mann
Journal:  Circ Heart Fail       Date:  2017-12       Impact factor: 8.790

Review 3.  Left ventricular assist device-induced reverse remodeling: it's not just about myocardial recovery.

Authors:  Karolina K Marinescu; Nir Uriel; Douglas L Mann; Daniel Burkhoff
Journal:  Expert Rev Med Devices       Date:  2016-12-22       Impact factor: 3.166

Review 4.  Reverse remodelling and myocardial recovery in heart failure.

Authors:  Gene H Kim; Nir Uriel; Daniel Burkhoff
Journal:  Nat Rev Cardiol       Date:  2017-09-21       Impact factor: 32.419

Review 5.  Immune Modulation in Heart Failure: the Promise of Novel Biologics.

Authors:  Paulino Alvarez; Alexandros Briasoulis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-15

Review 6.  LVAD as a Bridge to Remission from Advanced Heart Failure: Current Data and Opportunities for Improvement.

Authors:  Christos P Kyriakopoulos; Chris J Kapelios; Elizabeth L Stauder; Iosif Taleb; Rana Hamouche; Konstantinos Sideris; Antigone G Koliopoulou; Michael J Bonios; Stavros G Drakos
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

7.  Load-Dependent Changes in Left Ventricular Structure and Function in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure.

Authors:  Carla J Weinheimer; Attila Kovacs; Sarah Evans; Scot J Matkovich; Philip M Barger; Douglas L Mann
Journal:  Circ Heart Fail       Date:  2018-05       Impact factor: 8.790

Review 8.  Reverse Remodeling With Left Ventricular Assist Devices.

Authors:  Daniel Burkhoff; Veli K Topkara; Gabriel Sayer; Nir Uriel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 23.213

Review 9.  Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives.

Authors:  M Merlo; T Caiffa; M Gobbo; L Adamo; G Sinagra
Journal:  Int J Cardiol Heart Vasc       Date:  2018-03-08

10.  The Affordable Care Act's Hospital Readmissions Reduction Program: Has the Biology Had Time to Catch Up With the Regulation?

Authors:  Douglas L Mann; Gordon F Tomaselli
Journal:  JACC Basic Transl Sci       Date:  2016-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.